Company
Boston
Every investor coverage indicates participated in a round Sean M Healey and AMG Center for ALS raised.
Companies Sean M Healey and AMG Center for ALS acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Sabrina Paganoni | Biotech Dispatch |
Stories naming Sean M Healey and AMG Center for ALS. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
America's NIH has agreed to fund a program giving up to 200 ALS patients access to Neurizon Therapeutics' drug NUZ-001, with Melbourne-based Neurizon as subawardee and a Boston ALS centre running it.